TY - JOUR
T1 - Lifetime and baseline alcohol intakes and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition study
AU - Naudin, Sabine
AU - Li, Kuanrong
AU - Jaouen, Tristan
AU - Assi, Nada
AU - Kyrø, Cecilie
AU - Tjønneland, Anne
AU - Overvad, Kim
AU - Boutron-Ruault, Marie Christine
AU - Rebours, Vinciane
AU - Védié, Anne Laure
AU - Boeing, Heiner
AU - Kaaks, Rudolf
AU - Katzke, Verena
AU - Bamia, Christina
AU - Naska, Androniki
AU - Trichopoulou, Antonia
AU - Berrino, Franco
AU - Tagliabue, Giovanna
AU - Palli, Domenico
AU - Panico, Salvatore
AU - Tumino, Rosario
AU - Sacerdote, Carlotta
AU - Peeters, Petra H.
AU - Bueno-de-Mesquita, Bas
AU - Weiderpass Vainio, Elisabete
AU - Gram, Inger Torhild
AU - Skeie, Guri
AU - Chirlaque, Maria Dolores
AU - Rodríguez-Barranco, Miguel
AU - Barricarte, Aurelio
AU - Quirós, Jose Ramón
AU - Dorronsoro, Miren
AU - Johansson, Ingegerd
AU - Sund, Malin
AU - Sternby, Hanna
AU - Bradbury, Kathryn E.
AU - Wareham, Nick
AU - Riboli, Elio
AU - Gunter, Marc
AU - Brennan, Paul
AU - Duell, Eric J.
AU - Ferrari, Pietro
N1 - Funding Information:
Abbreviations: CI: confidence interval; EPIC: European Prospective Investigation into Cancer and Nutrition; HR: hazard ratio; IARC: International Agency for Research on Cancer; WCRF/AICR: World cancer research fund/American institute of cancer research Additional Supporting Information may be found in the online version of this article. Conflict of interest: None to declare. Grant sponsor: The Direction Générale de la Santé(French Ministry of Health); Grant number: GR-IARC-2003-09-12-01; Grant sponsor: The European Commission (Directorate General for Health and Consumer Affairs); Grant sponsor: The International Agency for Research on Cancer; Grant sponsor: The Danish Cancer Society (Denmark); Grant sponsor: The Ligue Contre le Cancer; Grant sponsor: The Institut Gustave Roussy; Grant sponsor: The Mutuelle Générale de l’Education Nationale; Grant sponsor: The Institut National de la Santé et de la Recherche Médicale (France); Grant sponsor: The Deutsche Krebshilfe; Grant sponsor: The Deutsches Krebsforschungszentrum; Grant sponsor: The Federal Ministry of Education and Research (Germany); Grant sponsor: The Hellenic Health Foundation; Grant sponsor: The Stavros Niarchos Foundation; Grant sponsor: The Hellenic Ministry of Health and Social Solidarity (Greece); Grant sponsor: The Italian Association for Research on Cancer and the National Research Council (Italy); Grant sponsor: The Dutch Ministry of Public Health, Welfare and Sports; Grant sponsor: The Netherlands Cancer Registry, LK Research Funds, Dutch Prevention Funds, the Dutch Zorg Onderzoek Nederland; Grant sponsor: The World Cancer Research Fund and Statistics Netherlands (the Netherlands); Grant sponsor: The Health Research Fund, Regional Governments of Andaluc′ya, Asturias, Basque Country, Murcia; Grant number: (Project 6236); Grant sponsor: Instituto de Salud Carlos III, Redes de Investigacion Cooperativa; Grant number: RD06/0020; Grant sponsor: The Swedish Cancer Society; Grant sponsor: The Swedish Scientific Council; Grant sponsor: The Regional Government of Skåne (Sweden); Grant sponsor: Cancer Research UK; Grant numbers: 14136 to EPIC-Norfolk, C570/A16491, C8221/A19170 to EPIC-Oxford; Grant sponsor: Medical Research Council; Grant numbers: 1000143 to EPIC-Norfolk, MR/M012190/1 to EPIC-Oxford; Grant sponsor: The Stroke Association, the British Heart Foundation, the Department of Health, the Food Standards Agency, the Wellcome Trust (UK); Grant sponsor: The Communautée de Recherche Académique de la région Auvergne Rhône-Alpes DOI: 10.1002/ijc.31367 This article was published online on 30 March 2018. It was discovered that footnotes were missing in Figure 1 caption. These have subsequently been added. This notice is included in the online and print versions to indicate that both have been corrected 24 April 2018. History: Received 29 Sep 2017; Accepted 2 Feb 2018; Online 10 Mar 2018 Correspondence to: Pietro Ferrari, Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer, WHO, 150 Cours Albert Thomas, 69372 Lyon CEDEX 08, France, Tel.: 33-472-738-031, E-mail: [email protected]
Publisher Copyright:
© 2018 IARC/WHO
PY - 2018/8/15
Y1 - 2018/8/15
N2 - Recent evidence suggested a weak relationship between alcohol consumption and pancreatic cancer (PC) risk. In our study, the association between lifetime and baseline alcohol intakes and the risk of PC was evaluated, including the type of alcoholic beverages and potential interaction with smoking. Within the European Prospective Investigation into Cancer and Nutrition (EPIC) study, 1,283 incident PC (57% women) were diagnosed from 476,106 cancer-free participants, followed up for 14 years. Amounts of lifetime and baseline alcohol were estimated through lifestyle and dietary questionnaires, respectively. Cox proportional hazard models with age as primary time variable were used to estimate PC hazard ratios (HR) and their 95% confidence interval (CI). Alcohol intake was positively associated with PC risk in men. Associations were mainly driven by extreme alcohol levels, with HRs comparing heavy drinkers (>60 g/day) to the reference category (0.1-4.9 g/day) equal to 1.77 (95% CI: 1.06, 2.95) and 1.63 (95% CI: 1.16, 2.29) for lifetime and baseline alcohol, respectively. Baseline alcohol intakes from beer (>40 g/day) and spirits/liquors (>10 g/day) showed HRs equal to 1.58 (95% CI: 1.07, 2.34) and 1.41 (95% CI: 1.03, 1.94), respectively, compared to the reference category (0.1-2.9 g/day). In women, HR estimates did not reach statistically significance. The alcohol and PC risk association was not modified by smoking status. Findings from a large prospective study suggest that baseline and lifetime alcohol intakes were positively associated with PC risk, with more apparent risk estimates for beer and spirits/liquors than wine intake.
AB - Recent evidence suggested a weak relationship between alcohol consumption and pancreatic cancer (PC) risk. In our study, the association between lifetime and baseline alcohol intakes and the risk of PC was evaluated, including the type of alcoholic beverages and potential interaction with smoking. Within the European Prospective Investigation into Cancer and Nutrition (EPIC) study, 1,283 incident PC (57% women) were diagnosed from 476,106 cancer-free participants, followed up for 14 years. Amounts of lifetime and baseline alcohol were estimated through lifestyle and dietary questionnaires, respectively. Cox proportional hazard models with age as primary time variable were used to estimate PC hazard ratios (HR) and their 95% confidence interval (CI). Alcohol intake was positively associated with PC risk in men. Associations were mainly driven by extreme alcohol levels, with HRs comparing heavy drinkers (>60 g/day) to the reference category (0.1-4.9 g/day) equal to 1.77 (95% CI: 1.06, 2.95) and 1.63 (95% CI: 1.16, 2.29) for lifetime and baseline alcohol, respectively. Baseline alcohol intakes from beer (>40 g/day) and spirits/liquors (>10 g/day) showed HRs equal to 1.58 (95% CI: 1.07, 2.34) and 1.41 (95% CI: 1.03, 1.94), respectively, compared to the reference category (0.1-2.9 g/day). In women, HR estimates did not reach statistically significance. The alcohol and PC risk association was not modified by smoking status. Findings from a large prospective study suggest that baseline and lifetime alcohol intakes were positively associated with PC risk, with more apparent risk estimates for beer and spirits/liquors than wine intake.
UR - http://www.scopus.com/inward/record.url?scp=85044518742&partnerID=8YFLogxK
U2 - 10.1002/ijc.31367
DO - 10.1002/ijc.31367
M3 - Article
AN - SCOPUS:85044518742
SN - 0020-7136
VL - 143
SP - 801
EP - 812
JO - International Journal of Cancer
JF - International Journal of Cancer
IS - 4
ER -